Jennifer Benna
Reno,NV
Summary
Dynamic sales leader with a proven track record in the biopharmaceutical sector, notably achieving beyond sales goals in every role, while excelling in patient-focused strategies. Expert in market access and forming strategic relationships, demonstrated through formulary wins and excellence in customer interactions. Skilled in leveraging competitive drive and relationship-building to deliver outstanding results.
Overview
20
20
years of professional experience
Work History
Sr. Executive, Institutional Accounts Specialist
Portola, Alexion, AstraZeneca (multiple Mergers)
Northern California And Nevada, CA, NV
07.2020 - Current
- Responsible for Acute Care Sales of company’s thrombosis reversal agent, Andexxa
- Q3 2024 # 4 Nationally, 167% to goal
- Winner, Circle of Excellence, top 10% in Sales For 2022
- Achieved formulary wins at Carson Tahoe Regional Hospital, Barton Memorial, and VA system
- Responsible for upcoming P&T meetings at UC Davis, Renown, Saint Mary’s and Northern Nevada.
- Nominated to represent national lead for VAMC and DOD workstream best practices and pull through operations.
- Regional lead for IDN operations at Prime, Sutter, Adventist.
- Extensive experience with UC Davis from ED to Cardiology customers.
- Fostered partnerships with industry leaders, enhancing company's credibility and access to new technologies.
- Maintained positive customer relations by addressing problems head-on and implementing successful corrective actions.
- Defined clear targets and objectives and communicated to other team members.
Critical Care Specialist
La Jolla Pharmaceutical Company
Northern California, Nevada And Washington , CA, NV, WA
06.2019 - 07.2020
- Responsible for delivering approved disease state education
- Building strategic relationships within Critical Care
- Delivery of approved Giapreza information to critical care nursing, pharmacy, physician medical teams within hospital
- Strategic pull through in top accounts to drive growth for Giapreza
- Partnering with hospital educators, ICU managers and staff to ensure education on Giapreza is conducted as appropriate
- Responsible for understanding P&T formulary processes in each hospital
- Account responsibility: Dignity, UC Davis, Sutter, CHI, Providence, UCSF, CPMC and Kaiser
- Worked well in a team setting, providing support and guidance.
- Demonstrated strong organizational and time management skills while managing multiple projects.
Luxury Real Estate Sales and Brokerage Partner
Benna Mountain Luxury/Tahoe Mountain Realty
Northern California And Nevada, CA, NV
12.2016 - 05.2019
- (Industry break and family business start up after biopharma layoff with Medicine's Company)
- Developed and implemented strategic plan for entering new markets, resulting in substantial increase in brand visibility and market share.
- Improved overall team productivity by introducing innovative project management tools and techniques.
Engagement Manager
The Medicines Company
Northern CA And Nevada, NV, CA
04.2008 - 06.2016
- Customer and science specialty role for Northern California/NV
- Responsible for over $2.5M dollars in sales for territory yearly
- Top 10 2013, 2015 National ranking
- Responsible for total pathway care- from patient entry in E.D. to advancing in cardiology care, or intensive care unit, to discharge for the following acute care drugs:
- Angiomax (cardiac cath lab)
- Co-promotion with Boston Scientific for stent launch
- Cleviprex (acute anti-hypertensive)
- Kengreal (launch July 2015)
- KOL development for product pathway in each drug cycle and care points in hospital
- Work with large systems: Dignity Healthcare, Sutter, UC Davis, UCSF, Renown, Premier, Novation and other large GPO's.
- Responsible for maintaining and developing key relationships with interventional cardiologists throughout territory
- Secured long-term accounts by recommending strategies to promote brand effectiveness and highlight product benefits.
Senior Specialty Account Manager
Enzon Pharmaceuticals
Scottsdale, Northern CA, AZ And CA
03.2006 - 04.2008
- Responsible for promoting IV Anti-fungal therapy ABELCET, novel pegylated Oncology (Acute lymphocytic leukemia) therapy ONCASPAR, and novel lymphomatous meningitis drug, DEPOCYT.
- Responsible for Institutions such as Stanford, Lucille Packard Children’s Hospital, University of California San Francisco Hospital (Children’s and Adult Onoclogy programs), Santa Clara Valley Hospital, and California Pacific Medical Center.
- Oncology driven protocol development with KOL’s such as Chris Dvorak at UCSF Children’s.
- Key focus for ONCASPAR was nursing education to prevent AE’s and early discontinuations.
- Worked closely with Nurse Educators, Hem/Onc’s and Staff to develop long standing relationship
- Worked with pharmacy, ICU’s, and Outpatient to develop throughput for continued Oncaspar infusions.
- Increased sales revenue by identifying and targeting high-potential accounts in the specialty market.
- Developed competitive analyses reports for senior leadership assessing strengths/weaknesses of rival products/services within the specialty market.
- Provided exceptional customer service by addressing account concerns promptly and thoroughly.
- Collaborated with upper management to implement continuous improvements and exceed team goals.
Clinical Trials Manager, Cardiothoracic Transplant
University Of Southern California, USC
Los Angeles, CA
07.2004 - 03.2006
- Pulmonary, Critical Care and Transplant Clinical Trial management from commencement to site close procedures.
- Infectious Disease expertise in fungal pathogens, clinical relevance to Solid Organ Transplant and Immunocompromised populations. ● Clinical Research Organization (CRO) liaison for all trials, including travel to appropriate meetings as a site representative.
- Managing 7-10 Phase II-Phase IV studies concurrently. ● Monitoring and data compliance for two Physician-initiated trials within the USC Cardiothoracic Transplant group.
- Regulatory and Source documentation, Case Report Form completion, Informed Consent process, Staff In-Service, Site Initiation and Close-Out, Interim monitoring.
- Enhanced patient safety by developing risk mitigation plans and closely monitoring adverse events during trials.
- Expedited trial timelines by proactively identifying potential bottlenecks and implementing solutions to address them effectively.
- Fostered strong relationships with investigators, ensuring consistent communication throughout trials for smooth operations.
Education
Bachelor of Science - Biology And Microbiology
Mount Saint Mary’s College
Los Angeles, CA01.2003
Skills
- Patient Focused
- Timely, precise and strategic through hospital and customer interactions
- Reimbursement and market access champion
- Relationship driven
- Competitive and results oriented
Timeline
Sr. Executive, Institutional Accounts Specialist
Portola, Alexion, AstraZeneca (multiple Mergers)
07.2020 - Current
Critical Care Specialist
La Jolla Pharmaceutical Company
06.2019 - 07.2020
Luxury Real Estate Sales and Brokerage Partner
Benna Mountain Luxury/Tahoe Mountain Realty
12.2016 - 05.2019
Engagement Manager
The Medicines Company
04.2008 - 06.2016
Senior Specialty Account Manager
Enzon Pharmaceuticals
03.2006 - 04.2008
Clinical Trials Manager, Cardiothoracic Transplant
University Of Southern California, USC
07.2004 - 03.2006
Bachelor of Science - Biology And Microbiology
Mount Saint Mary’s College